Drug Profile
KTX 0101
Alternative Names: Sodium beta-hydroxybutyrateLatest Information Update: 21 Aug 2019
Price :
$50
*
At a glance
- Originator BTG
- Developer KetoCytonyx
- Class Ketone bodies; Neuroprotectants; Small molecules
- Mechanism of Action Free radical scavengers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cognition disorders